Year: 2022

Figure 1 Internet of Things Market SizeFigure 2 Customer ProjectsFigure 3 Tekumo Product SuiteCOLORADO SPRINGS, Colo., Nov. 18, 2022 (GLOBE NEWSWIRE) — This is the BCNN Board of Directors letter to shareholders. To our Shareholders This is the first letter to our shareholders, and we are excited to share with you our vision for the Company after our merger with Tekumo LLC in June. Tekumo means “Tech Cloud” in Japanese. In a world of smart, connected devices, there remains a “last-mile” issue of installing, monitoring, and managing such systems. Product and service companies all need a new service model. Tekumo is reinventing that process by deploying an intelligent service delivery platform that provides the “human link” in the installation and maintenance of technology systems, as well as providing a “smart interface”...

The shares in Mowi ASA will be traded ex-dividend of NOK 1.70 as from today 18 November 2022. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

SHANGHAI, China, Nov. 17, 2022 (GLOBE NEWSWIRE) — 360 DigiTech, Inc. (NASDAQ: QFIN) (“360 DigiTech” or the “Company”), a leading Credit-Tech platform in China, today announced the launch of its global offering (the “Global Offering”) of 5,540,000 Class A ordinary shares of the Company, which comprises a Hong Kong public offering of initially 560,000 Class A ordinary shares commencing today (the “Hong Kong Public Offering”) and an international offering of initially 4,980,000 Class A ordinary shares commencing today (the “International Offering”), and listing of the Company’s Class A ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) under the stock code “3660.” The Company’s American depositary shares (the “ADSs”), each representing two Class A ordinary shares of the Company,...

-Agreement Provides Flexible Funding on Path to NDA Submission for PAX-101- TARRYTOWN, NY, Nov. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that the Company has entered into a purchase agreement and registration rights agreement (together, the “Agreement”) for up to $20 million with Lincoln Park Capital Fund, LLC (“Lincoln Park”). Under the terms and conditions of the Agreement, including effectiveness of a related registration statement, the Company has the right, but not the obligation, to sell up to $20 million of its shares of common stock to Lincoln Park over a 30-month period,...

RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the pricing of an underwritten public offering of 7,700,000 shares of its common stock at a public offering price of $6.50 per share, for total gross proceeds of $50,050,000. All of the shares in the offering will be sold by G1 Therapeutics. In addition, G1 Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 shares of common stock at the public offering price, less the underwriting discount. The offering is expected to close on November 22, 2022, subject to customary closing conditions. Cowen and Raymond James are acting as joint book-running managers for the offering. Needham & Company and Wedbush PacGrow are acting as lead...

KING OF PRUSSIA, Pa., Nov. 17, 2022 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, announced today the pricing of an underwritten offering of 1,500,000 shares of its Class A common stock by Jeffrey R. Westphal at a price to the public of $15.15 per share. The offering is expected to close on November 22, 2022, subject to the satisfaction of customary closing conditions. Vertex will not receive any of the proceeds from the sale of shares in the offering. Goldman Sachs & Co. LLC is serving as the sole underwriter for the offering. A shelf registration statement relating to these securities was filed with the U.S. Securities and Exchange Commission (“SEC”) on July 15, 2022, and was declared effective by the SEC on July 25, 2022. The registration statement...

DALLAS, Nov. 17, 2022 (GLOBE NEWSWIRE) — GWG Holdings, Inc. (OTC: GWGHQ) (the “Company”), a financial services firm based in Dallas, Texas, today announced that Timothy Evans, the Company’s former Chief Financial Officer, David Chavenson and David De Weese have resigned from their positions on the Company’s board of directors, and any related committee roles they held, effective immediately. Independent director Tony Horton and Jeffrey S. Stein, the Company’s President, Chief Executive Officer and Chief Restructuring Officer, remain on the Company’s board of directors. The Company expects to provide additional information in the coming days. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange...

ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) —   MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today reported that the U.S. Food and Drug Administration announced the approval of the Biologics License Application (BLA) for teplizumab, an anti-CD3 monoclonal antibody that was previously developed by MacroGenics.  Teplizumab was acquired by Provention Bio, Inc. in May 2018 pursuant to an asset purchase agreement.  “We are very pleased to see the culmination of years of effort by Provention, MacroGenics, and tireless champions in academia and government, with the achievement of the approval of teplizumab,” said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. “We applaud this outcome, which represents...

The 18-story, 344-unit luxury mixed-use apartment community totals more than 282k square feet and includes more than 10k square feet of ground-floor retail spaceBroad & Noble Topping-Out Celebration in Philadelphia, PA Philadelphia City Council member Mark Squilla joins members of the Broad & Noble development team, including Toll Brothers Apartment Living, Sundance Bay, and Clemens Construction Company, for a ceremonial beam-signing before the beam was hoisted to the top of the construction site.Broad & Noble Topping-Out Celebration in Philadelphia, PA Members of the Ironworkers Local Union 401 take part in a ceremonial beam-signing before the beam was hoisted to the top of the construction site.PHILADELPHIA, Nov. 17, 2022 (GLOBE NEWSWIRE) — Toll Brothers Apartment Living®, the rental subsidiary of Toll Brothers,...

IRVINE, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced that it has closed its previously announced private placement with several institutional investors for the issuance and sale of 2,619,911 shares of common stock (or pre-funded warrants in lieu thereof) and preferred investment options to purchase up to 10,619,911 shares of common stock at an offering price of $2.862692 per share (or pre-funded warrant) and accompanying preferred investment options, priced at-the-market under Nasdaq rules. The preferred investment options are exercisable immediately upon issuance, have a term of three years and an exercise price of $2.356 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds...